A Phase Ⅱ Clinical Study Trial of Felbinac Trometamol Injection in China
Clinical trial NCT03872830 · COMPLETED
Trial details
- NCT number
- NCT03872830
- Sponsor
- Shijiazhuang Yiling Pharmaceutical Co. Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-27
- Primary completion
- 2019-09-30
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.